← Back to Search

Blinded CGM for Gestational Diabetes (CGMSGDMLABOR Trial)

N/A

Waitlist Available

Led By Karen Elkind-Hirsch, PhD

Research Sponsored by Woman's

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from 6 to 12 weeks after delivery

Awards & highlights

CGMSGDMLABOR Trial Summary

This trial looks at whether using a continuous glucose monitor (CGM) to track blood sugar levels during labor can help improve glycemia in pregnant women with gestational diabetes.

Eligible Conditions

Gestational Diabetes

CGMSGDMLABOR Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from 6 to 12 weeks after delivery

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from 6 to 12 weeks after delivery

This trial's timeline: 3 weeks for screening, Varies for treatment, and from 6 to 12 weeks after delivery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Average percentage time in target glucose range

Secondary outcome measures

average time spent in hyperglycemia (time above target range)

average time spent in hypoglycemia (time below target range)

neonatal hypoglycemia

Other outcome measures

postpartum 2 hour 75 gram OGTT results from mother

CGMSGDMLABOR Trial Design

1Treatment groups

Experimental Treatment

Group I: Blinded CGMExperimental Treatment1 Intervention

Blinded continuous glucose monitor Dexcom G6Pro

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Blinded CGM

2021

N/A

~230

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Woman'sLead Sponsor

17 Previous Clinical Trials

1,393 Total Patients Enrolled

DexCom, Inc.Industry Sponsor

137 Previous Clinical Trials

29,789 Total Patients Enrolled

Karen Elkind-Hirsch, PhDPrincipal InvestigatorWoman's Hospital, Louisiana

3 Previous Clinical Trials

297 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are under observation in this research project?

"Indeed, the data hosted on clinicaltrials.gov affirms that this medical experiment is presently enrolling participants. This trial was initially made public on November 1st 2021 and has been updated recently on November 15th 2021; it seeks 40 patients from a single site."

Answered by AI

Are there vacancies for participants in this medical research endeavor?

"Affirmative. Clinicaltrials.gov suggests that this clinical trial is currently enrolling participants, with the initial posting being on November 1st 2021 and the last update taking place on November 15th 2021. The research requires 40 volunteers across a single site to be admitted into the study."

Answered by AI

Who meets the eligibility criteria for this experimental protocol?

"This research seeks 40 individuals between the ages of 18 and 45 who are pregnant with diabetes. In order to be eligible, they must have a labor scheduled for term induction (37-40 weeks) and their pregnancy has to be singleton."

Answered by AI

Does this clinical study have any age restrictions, specifically for individuals over seventy-five?

"This clinical trial is only available to patients aged 18 to 45. If a person's age falls outside of this range, there are 13 studies for people under the lower limit and 48 trials targeting those above 65 years old."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The CGMS in GDM Labor and Delivery Study

2021. "The CGMS in GDM Labor and Delivery Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05067075.